Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CellGenix Technologie Transfer GmbH
DescriptionRecombinant vaccine containing a histidine-tagged idiotype immunoglobulin Fab fragment of clonal B cell receptor
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationB cell lymphoma
Indication DetailsTreat diffuse large B cell lymphoma (DLBCL)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today